Molecular glues, tiny molecules that connect one protein to another, are promising targets for pharmaceutical research. By ...

By putting a carbon atom in place of a core oxygen, chemists constructed an opioid that blocks pain with less respiratory ...

A major scientific advance in protein modeling developed by Microsoft Research AI for Science, has been published in Science.

The de novo design of drug molecules is recognized as a time-consuming and costly process, and computational approaches have been applied in each stage of the drug discovery pipeline. Variational ...

Article citations More>> Yuan, Z. and Dong, D.M. (2022) Near-Infrared Spectroscopy Measurement of Contrastive Variational Autoencoder and Its Application in the Detection of Liquid Sample.

Compute efficient generative AI foundation model for small molecule drug discovery start-up announces funding from leading AI and biotech investors.

Variational AI Announces Oversubscribed $5.5 Million Financing to Launch Foundation Model for Small Molecule Drug Discovery ...

About Variational AI Variational AI is redefining the unit economics of drug discovery through the power of generative AI. The founding machine learning (ML) team comes from leading AI research labs ...

Innovative Approach to Drug Discovery The shortlisted molecules were developed using Variational AI’s proprietary Enki™ foundation model platform to generate novel chemical compounds from the ...

Third-party investment in AI-enabled drug discovery more than doubled annually for five years, increasing from $2.4 billion in 2020 to $5.2 billion in 2021.

Discovery of Vascular Endothelial Growth Factor Receptor 2 Inhibitors Employing Junction Tree Variational Autoencoder with Bayesian Optimization and Gradient Ascent ...